Renal Failure
Volume 42, 2020 - Issue 1
Open access
1,893
Views
7
CrossRef citations to date
0
Altmetric
Clinical Study
Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy
Yaling GuoDepartment of Nephrology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People’s Republic of ChinaView further author information
, Xueping WuDepartment of Nephrology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People’s Republic of ChinaView further author information
, Lei LiuDepartment of Nephrology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People’s Republic of ChinaView further author information
, Haifeng ZhangDepartment of Nephrology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People’s Republic of ChinaView further author information
, Lijuan YangDepartment of Nephrology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People’s Republic of ChinaView further author information
& Weidong ChenDepartment of Nephrology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People’s Republic of ChinaCorrespondence[email protected]
View further author information
View further author information
Pages 122-130
|
Received 12 Sep 2019, Accepted 29 Nov 2019, Published online: 20 Jan 2020
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.